0001437749-14-011308.txt : 20140624 0001437749-14-011308.hdr.sgml : 20140624 20140616170918 ACCESSION NUMBER: 0001437749-14-011308 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140612 FILED AS OF DATE: 20140616 DATE AS OF CHANGE: 20140616 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Spotts Stephen L CENTRAL INDEX KEY: 0001413746 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 14923464 MAIL ADDRESS: STREET 1: C/O GENOPTIX INC STREET 2: 2110 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 rdgdoc.xml FORM 4 X0306 4 2014-06-12 0001586049 Oxford Immunotec Global PLC OXFD 0001413746 Spotts Stephen L C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 SHARE OPTION (RIGHT TO BUY) 16.86 2014-06-12 4 A 0 7457 0 A 2024-06-12 ORDINARY SHARES 7457 7457 D The option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant. /s/ Anthony P. Ferman, as attorney in fact for Stephen Spotts 2014-06-16